Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenarians

Journal of the American Geriatrics Society

Volumn 53, Issue 9, 2005, Pages 1552-1558

  Lehtimäki, Terho ^a   Ojala, Petri ^a,b   Rontu, Riikka ^a   Goebeler, Sirkka ^c   Karhunen, Pekka J ^c   Jylhä, Marja ^b   Mattila, Kari ^a   Metso, Saara ^a   Jokela, Hannu ^a   Nikkilä, Matti ^d   Wuolijoki, Erkki ^a   Hervonen, Antti ^b   Hurme, Mikko ^c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^d Tampere City Hospital   (Finland)

Author keywords

C reactive protein; Cholesterol; Inflammation; Interleukin 6; Nonagenarians

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LIPID BLOOD LEVEL; MALE; NONGENARIAN; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ADULT; AGE; BLOOD; COMPARATIVE STUDY; MIDDLE AGED;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 27744602196     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53484.x     Document Type: Article

References (29)

1. Ridker PM, Hennekens CH, Buring JE et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
2. Ridker PM, Rifai N, Rose L et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565.
3. Volpato S, Guralnik JM, Ferrucci L et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: The women's health and aging study. Circulation 2001;103:947-953.
4. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 1999;52:465-477.
5. Banks RE, Forbes MA, Storr M et al. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol 1995;102:217-223.
6. Lu ZY, Brailly H, Wijdenes J et al. Measurement of whole body interleukin-6 (IL-6) production: Prediction of the efficacy of anti-IL-6 treatments. Blood 1995;86:3123-3131.
7. Fernandez-Real JM, Broch M, Vendrell J et al. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 2000;85:1334-1339.
8. Yudkin JS, Stehouwer CD, Emeis JJ et al. C-reactive protein in healthy subjects. Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
9. Pickup JC, Mattock MB, Chusney GD et al. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997;40:1286-1292.
10. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245-270.
11. Romano M, Sironi M, Toniatti C et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997;6: 315-325.
12. Jenny NS, Tracy RP, Ogg MS et al. In the elderly, interleukin-6 plasma levels and the -174G > C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 2002;22:2066-2071.
13. Vasan RS, Sullivan LM, Roubenoff R et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction. The Framingham Heart Study. Circulation 2003;107:1486-1491.
14. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003;114:180-187.
15. Reuben DB, Cheh AI, Harris TB et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002;50:638-644.
16. Luc G, Bard JM, Juhan-Vague I et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. The PRIME Study. Arterioscler Thromb Vasc Biol 2003;23:1255-1261.
17. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 2003;41:37S-42S.
18. Wei J, Xu H, Davies JL et al. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 1992;51:1953-1956.
19. Daynes RA, Araneo BA, Ershler WB et al. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993;150: 5219-5230.
20. Heliovaara M, Aromaa A, Klaukka T et al. Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol 1993;46:181-191.
21. Mendall MA, Patel P, Asante M et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273-277.
22. Gordon T. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 1990;131:942.
23. Bhakdi S, Torzewski M, Klouche M et al. Complement and atherogenesis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 1999;19:2348-2354.
24. Taskinen S, Kovanen PT, Jarva H et al. Binding of C-reactive protein to modified low-density-lipoprotein particles: Identification of cholesterol as a novel ligand for C-reactive protein. Biochem J 2002;367:403-412.
25. Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989;30:39-49.
26. Memon RA, Staprans I, Noor M et al. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 2000;20:1536-1542.
27. Hu P, Seeman TE, Harris TB et al. Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur Studies of Successful Aging. J Am Geriatr Soc 2003;51: 80-84.
28. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200.
29. Fagiolo U, Cossarizza A, Scala E et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993;23:2375-2378.